Novel percutaneous VAD for high risk-PCI feasible, safe in small study
Use of a novel miniaturized, expandable percutaneous ventricular assist device was shown to be feasible and potentially safe in a small study of six high-risk patients undergoing PCI, a speaker reported.The first-in-human data of a novel percutaneous VAD system (Supira Medical) for high-risk PCI were presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.